L-Tryptophan

From NuGOwiki

(Redirected from HMDB00929)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

L-Tryptophan
2D structure for L-Tryptophan
Chemical Name (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid
Chemical Formula C11H12N2O2
CAS Number 73-22-3
Chemical Information HMDB00929
Biochemical Taxonomy

  • Amino Acids

Functional Taxonomy

  • Essential Amino Acid

Nutritional Taxonomy Not Available
Metabolic Pathways Not Available
Biofluid Location

  • Blood
  • Cerebrospinal Fluid (CSF)
  • Saliva
  • Urine

Tissue Location

  • Nerves
  • Fibroblasts

Normal Biofluid Concentrations

  • Blood: 101.5 +/- 27.2 uM
  • Blood: 44.0 (37.0-51.0) uM
  • Blood: 45.0 +/- 9.0 uM
  • Blood: 48.7 +/- 11.6 uM
  • Cerebrospinal Fluid (CSF): 1.3 +/- 0.4 umol/mmol creatinine
  • Cerebrospinal Fluid (CSF): 2.0 (1.2-2.5) uM
  • Cerebrospinal Fluid (CSF): 2.0 +/- 0.53 uM
  • Cerebrospinal Fluid (CSF): 2.32 +/- 0.09 uM
  • Cerebrospinal Fluid (CSF): 20.4 +/- 8.2 uM
  • Cerebrospinal Fluid (CSF): 5 +/- 3 uM
  • Saliva: <1.00 uM
  • Urine: 5.263 (1.316-9.211) umol/mmol creatinine
  • Urine: 7.84 +/- 8.63 umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Acute seizures
  • Epilepsy treated with phenytoin (Intoxicated)
  • Epilepsy treated with phenytoin (after Intoxication)
  • Epilepsy with borderline folate
  • Epilepsy with borderline thiamine
  • Epilepsy with low thiamine
  • Friedrich's Ataxia
  • Hartnup Disease
  • Hypothyroidism
  • Juvenile myoclonic epilepsy (JME)
  • Leukemia
  • Leukemia with CNS disease
  • Olivopontocerebral Atrophy
  • Probable Alzheimer's Disease
  • Refractory localization-related epilepsy (RLE)
  • Schizophrenia (Men)
  • Schizophrenia (Women)
  • Spastic Ataxia
  • hypothyroid patients

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Acute seizures): 31.6 (29.6-33.6) uM
  • Blood (Juvenile myoclonic epilepsy (JME)): 37.2 (34.3-40.1) uM
  • Blood (Probable Alzheimer's Disease): 33.06 +/- 8.99 uM
  • Blood (Refractory localization-related epilepsy (RLE)): 53.3 (50.3-56.3) uM
  • Blood (Schizophrenia (Men)): 83.3 +/- 26.0 uM
  • Blood (Schizophrenia (Women)): 80.2 +/- 22.0 uM
  • Cerebrospinal Fluid (CSF) (Epilepsy treated with phenytoin (Intoxicated)): 11.5 +/- 8.2 uM
  • Cerebrospinal Fluid (CSF) (Epilepsy treated with phenytoin (after Intoxication)): 1.6+/- 0.57 uM
  • Cerebrospinal Fluid (CSF) (Epilepsy with borderline folate): 1.7 +/- 0.27 uM
  • Cerebrospinal Fluid (CSF) (Epilepsy with borderline thiamine): 14.3 +/- 12.5 uM
  • Cerebrospinal Fluid (CSF) (Epilepsy with low thiamine): 1.7 +/- 0.4 uM
  • Cerebrospinal Fluid (CSF) (Friedrich's Ataxia): 2.4 +/- 0.13 uM
  • Cerebrospinal Fluid (CSF) (Hartnup Disease): 1.0 +/- 0.2 uM
  • Cerebrospinal Fluid (CSF) (Hypothyroidism): 0.0016 +/- 0.0003 uM
  • Cerebrospinal Fluid (CSF) (Hypothyroidism): 0.0018 +/- 0.0003 uM
  • Cerebrospinal Fluid (CSF) (Leukemia with CNS disease): 12.8 +/- 3.5 uM
  • Cerebrospinal Fluid (CSF) (Leukemia): 13.0 +/- 5.2 uM
  • Cerebrospinal Fluid (CSF) (Olivopontocerebral Atrophy): 2.42 +/- 0.14 uM
  • Cerebrospinal Fluid (CSF) (Spastic Ataxia): 1.80 +/- 0.2 uM
  • Cerebrospinal Fluid (CSF) (hypothyroid patients): 1.8 +/- 0.3 uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
Tryptophan is an essential amino acid which is the precursor of serotonin. Serotonin is a brain neurotransmitter, platelet clotting factor and neurohormone found in organs throughout the body. Metabolism of tryptophan to serotonin requires nutrients such as vitamin B6, niacin and glutathione. Niacin is an important metabolite of tryptophan. High corn or other tryptophan-deficient diets can cause pellagra, which is a niacin-tryptophan deficiency disease with symptoms of dermatitis, diarrhea and dementia. Inborn errors of tryptophan metabolism exist where a tumor (carcinoid) makes excess serotonin. Hartnup's disease is a disease where tryptophan and other amino acids are not absorbed properly. Tryptophan supplements may be useful in each condition, in carcinoid replacing the over-metabolized nutrient and in Hartnup's supplementing a malabsorbed nutrient. Some disorders of excess tryptophan in the blood may contribute to mental retardation. Assessment of tryptophan deficiency is done through studying excretion of tryptophan metabolites in the urine or blood. Blood may be the most sensitive test because the amino acid tryptophan is transported in a unique way. Increased urination of tryptophan fragments correlates with increased tryptophan degradation, which occurs with oral contraception, depression, mental retardation, hypertension and anxiety states. The requirement for tryptophan and protein decreases with age. Adults' minimum daily requirement is 3 mg/kg/day or about 200 mg a day. This may be an underestimation, for there are 400 mg of tryptophan in just a cup of wheat germ. A cup of low fat cottage cheese contains 300 mg of tryptophan and chicken and turkey contain up to 600 mg per pound. (http://www.dcnutrition.com)

Biological Function

guidelines
Low plasma tryprophan is fasting conditions results in reduced formation of serotonin in the brain (from: laboratory evaluations in molcular medicine, nutrients, toxicants and cell regulators, 2005, J. Alexander Bralley and Richard S. Lord, ISBN 0-9673949-3-7)

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Acute seizures
  • Epilepsy treated with phenytoin (Intoxicated)
  • Epilepsy treated with phenytoin (after Intoxication)
  • Epilepsy with borderline folate
  • Epilepsy with borderline thiamine
  • Epilepsy with low thiamine
  • Friedrich's Ataxia
  • Hartnup Disease
  • Hypothyroidism
  • Juvenile myoclonic epilepsy (JME)
  • Leukemia
  • Leukemia with CNS disease
  • Olivopontocerebral Atrophy
  • Probable Alzheimer's Disease
  • Refractory localization-related epilepsy (RLE)
  • Schizophrenia (Men)
  • Schizophrenia (Women)
  • Spastic Ataxia
  • hypothyroid patients

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines